BioPh Japan 2012

The Japanese pharmaceutical manufacturers have been eager to catch up the US and European players in the bio field by investing and cooperating with bio ventures & universities. The government has also been investing in infrastructure development such as bio industrial cluster projects and setting up support programs for bio ventures & universities in order to enhance Japan’s bio pharma industry.

Biotechnology-based drugs are anticipated to be one of the key drivers of the pharmaceutical market and this is reflected in the growing number biotechnology based drugs among newly approved medicines.

BioPh brings bio Solutions to CPhI Japan and is for companies and organisations involved in the research and development of new treatment methods arising from biotechnical processes or which are derived from, or use live organisms. If you are a supplier of bio pharma raw materials, services or equipment, don’t miss this opportunity to enjoy enhanced visibility by exhibiting in this hot-topic pavilion.